Editor: What To Know
- Envista Holdings Corporation CEO Amir Aghdaei said, “We are excited to unite our imaging portfolio under the DEXIS brand and unveil our new DEXIS logo that will be featured on our entire imaging portfolio.
- We have one of the largest installed bases of dental imaging devices in the industry with over 150,000 imaging devices currently utilized in dental practices.
- Headquartered in the United States, DEXIS is present in over 50 countries and has a workforce of approximately 1,000 employees.
DEXIS: Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced Envista’s KaVo imaging business will be re-branded as “DEXIS”.
Dental professionals have known the DEXIS brand as the leader in digital intraoral radiography and diagnostic software innovation for over 20 years. The DEXIS brand will now represent a full portfolio of award-winning imaging and digital solutions including cone-beam computed tomography (CBCT), handheld x-rays, intraoral scanners, sensors, and navigated surgical solutions.
DEXIS will combine other leading brands including i-CAT, Gendex, Instrumentarium, SOREDEX, and NOMAD, which with DEXIS are pioneers in x-ray generation, digital intraoral radiography, panoramic and cephalometric imaging, and 3D CBCT imaging. We have one of the largest installed bases of dental imaging devices in the industry with over 150,000 imaging devices currently utilized in dental practices. End-users of imaging devices can utilize our new diagnostics and treatment planning software suite DTX Studio to access all clinical patient images in one place, using one software.
Envista Holdings Corporation CEO Amir Aghdaei said, “We are excited to unite our imaging portfolio under the DEXIS brand and unveil our new DEXIS logo that will be featured on our entire imaging portfolio. This is one step in our continued efforts to create integrated, digital workflows that connect all our products and enable dental professionals to treat and improve more patient lives. We are living out our strategy to digitize, personalize, and democratize dentistry and look forward to the future.”
Headquartered in the United States, DEXIS is present in over 50 countries and has a workforce of approximately 1,000 employees. Over the rest of 2022, the imaging portfolio will transition in branding from KaVo to DEXIS with different schedules by product and by region. DEXIS continues to value its distributor partnerships and is excited to partner with distributors around the world to bring end-to-end, digital, diagnostic workflow solutions to dental professionals.